Examines the role of in-house strains in microbiological assays, indicating their importance for the pharmaceutical industry.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Daniel José Cardoso da Silva (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: